Merck sues US government over drug price negotiation powers.
TL;DR Summary
Merck has filed a lawsuit against the US government, accusing it of "extortion" over its attempts to control drug prices. The lawsuit claims that the government is violating the company's constitutional rights by threatening to withhold Medicare coverage for its drugs if it does not comply with price controls. Merck argues that the government is attempting to force it to sell its drugs at a loss, which would harm patients and undermine innovation in the pharmaceutical industry.
- Merck accuses US of 'extortion' in lawsuit against drug price controls Financial Times
- Merck Sues Over Medicare Drug-Price Negotiation Law The New York Times
- Merck sues Biden administration over Medicare drug price negotiations CNBC
- Merck sues US government to halt Medicare drug price negotiation Reuters
- Merck Challenges U.S. Government's New Powers to Negotiate Drug Prices The Wall Street Journal
Reading Insights
Total Reads
0
Unique Readers
8
Time Saved
0 min
vs 1 min read
Condensed
34%
117 → 77 words
Want the full story? Read the original article
Read on Financial Times